Renasant Bio
Berkeley
About Renasant Bio
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small-molecule treatments. The company aims to pioneer next-generation therapies that target the underlying mechanisms of ADPKD, improving patient outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $54.5M
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: renasantbio.com
- Phone: +1 650-223-5603
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/renasant-bio-41402 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.